Bio-UV Group stock plummets 7%, hitting lowest level since 2018 following earnings release
The publication of half-year results this morning failed to reassure markets: Bio-UV Group shares are experiencing one of their worst declines of the year, recording an unprecedented low in intraday trading since 2018. The marked contraction in profitability is weighing on the valuation of a small cap already weakened over the long term.
Eight-year low recorded in trading following the publication of first-half 2026 results
The Bio-UV Group share falls 7.69% to €1.20 during the session, after touching €1.19 intraday, its lowest level since 2018. This floor, a former absolute downside record, is reached following the publication of first-half 2026 results: revenue virtually flat at €20.1 million, but EBITDA margin fell to 12.5% versus 17.3% a year earlier. International momentum remains positive, with a 7% increase driven by Asia, but it does not offset the decline in French business, penalized by the swimming pool segment and a commercial reorganization. Over the week, the share has already fallen 6.56%, and is down 11.68% over three months, a sign of persistent pressure well preceding this session.
Three moving averages above the price, RSI at 43 and distant resistance levels
The technical configuration reflects the extent of the decline. The price at €1.20 is trading below the 20-day moving average (€1.33, a difference of -9.77%), the 50-day moving average (€1.33, same difference) and the 200-day moving average (€1.37, a difference of -12.41%): the three moving averages form a ceiling that the security has been attempting to reclaim for several weeks without success. The RSI at 43 remains in neutral territory but oriented downward, without an immediate rebound signal.
The former support at €1.30 is now a resistance level to reclaim, while the next identified resistance is located at €1.41, approximately 18% above the current price. Over one year, the share has lost 25%, illustrating an unfavorable underlying trend that the deterioration in half-year profitability is reinforcing.
